Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ugo Limbruno

Showing results (121-130 of 166) with videos related to

Pageof 17
Sort By:
Giornale Italiano Di Cardiologia (2006)|April 18, 2019
[A strategic roadmap of the Italian Society of Interventional Cardiology (SICI-GISE) to ensure patient's access to appropriate treatment]Giuseppe Tarantini, Giuseppe Musumeci, Giovanni Esposito, et al.
Giornale Italiano Di Cardiologia (2006)|October 9, 2019
[Italian certification for interventional cardiologists from the Italian Society of Interventional Cardiology (SICI-GISE)]Francesco Saia, Antonio Giulio Bruno, Anna Franzone, et al.
Giornale Italiano Di Cardiologia (2006)|October 9, 2019
[Online Addenda: Italian certification for interventional cardiologists from the Italian Society of Interventional Cardiology (SICI-GISE)]Francesco Saia, Antonio Giulio Bruno, Anna Franzone, et al.
Giornale Italiano Di Cardiologia (2006)|March 24, 2020
[PCSK9 inhibitor use in high cardiovascular risk patients: an interventionalist's overview on efficacy, current recommendations and factual prescription]Giulia Masiero, Anna Franzone, Tania Silvestri, et al.
International Journal of Cardiology. Heart & Vasculature|July 25, 2022
Adherence of ticagrelOr in real world patients with aCute coronary syndrome: The AD-HOC studyLuigi Fiocca, Roberta Rossini, Greta Carioli, et al.
American Heart Journal|December 19, 2015
Randomized evaluation of intralesion versus intracoronary abciximab and aspiration thrombectomy in patients with ST-elevation myocardial infarction: The COCTAIL II trialFrancesco Prati, Enrico Romagnoli, Ugo Limbruno, et al.
Giornale Italiano Di Cardiologia (2006)|April 12, 2017
[Bioequivalence and excipients: the case of tirofiban. A warning from the Italian Society of Interventional Cardiology (SICI-GISE)]Marianna Adamo, Roberto Bonmassari, Guglielmo Bernardi, et al.
Circulation. Cardiovascular Interventions|December 15, 2016
Clinical Impact of Suboptimal Stenting and Residual Intrastent Plaque/Thrombus Protrusion in Patients With Acute Coronary Syndrome: The CLI-OPCI ACS Substudy (Centro per la Lotta Contro L'Infarto-Optimization of Percutaneous Coronary Intervention in Acute Coronary Syndrome)Francesco Prati, Enrico Romagnoli, Laura Gatto, et al.
Journal of the American College of Cardiology|January 30, 2016
Cyclosporine A in Reperfused Myocardial Infarction: The Multicenter, Controlled, Open-Label CYCLE TrialFilippo Ottani, Roberto Latini, Lidia Staszewsky, et al.
Giornale Italiano Di Cardiologia (2006)|July 20, 2019
[ANMCO/SIC/GISE/ARCA/SIRM Consensus document: Description of coronary atherosclerosis for diagnostic, prognostic and therapeutic purposes]Giancarlo Casolo, Maurizio Giuseppe Abrignani, Antonio Francesco Amico, et al.
Pageof 17

Showing results (121-130 of 166) with videos related to

Sort By:
Pageof 17
Giornale Italiano Di Cardiologia (2006)|April 18, 2019
[A strategic roadmap of the Italian Society of Interventional Cardiology (SICI-GISE) to ensure patient's access to appropriate treatment]Giuseppe Tarantini, Giuseppe Musumeci, Giovanni Esposito, et al.
Giornale Italiano Di Cardiologia (2006)|October 9, 2019
[Italian certification for interventional cardiologists from the Italian Society of Interventional Cardiology (SICI-GISE)]Francesco Saia, Antonio Giulio Bruno, Anna Franzone, et al.
Giornale Italiano Di Cardiologia (2006)|October 9, 2019
[Online Addenda: Italian certification for interventional cardiologists from the Italian Society of Interventional Cardiology (SICI-GISE)]Francesco Saia, Antonio Giulio Bruno, Anna Franzone, et al.
Giornale Italiano Di Cardiologia (2006)|March 24, 2020
[PCSK9 inhibitor use in high cardiovascular risk patients: an interventionalist's overview on efficacy, current recommendations and factual prescription]Giulia Masiero, Anna Franzone, Tania Silvestri, et al.
International Journal of Cardiology. Heart & Vasculature|July 25, 2022
Adherence of ticagrelOr in real world patients with aCute coronary syndrome: The AD-HOC studyLuigi Fiocca, Roberta Rossini, Greta Carioli, et al.
American Heart Journal|December 19, 2015
Randomized evaluation of intralesion versus intracoronary abciximab and aspiration thrombectomy in patients with ST-elevation myocardial infarction: The COCTAIL II trialFrancesco Prati, Enrico Romagnoli, Ugo Limbruno, et al.
Giornale Italiano Di Cardiologia (2006)|April 12, 2017
[Bioequivalence and excipients: the case of tirofiban. A warning from the Italian Society of Interventional Cardiology (SICI-GISE)]Marianna Adamo, Roberto Bonmassari, Guglielmo Bernardi, et al.
Circulation. Cardiovascular Interventions|December 15, 2016
Clinical Impact of Suboptimal Stenting and Residual Intrastent Plaque/Thrombus Protrusion in Patients With Acute Coronary Syndrome: The CLI-OPCI ACS Substudy (Centro per la Lotta Contro L'Infarto-Optimization of Percutaneous Coronary Intervention in Acute Coronary Syndrome)Francesco Prati, Enrico Romagnoli, Laura Gatto, et al.
Journal of the American College of Cardiology|January 30, 2016
Cyclosporine A in Reperfused Myocardial Infarction: The Multicenter, Controlled, Open-Label CYCLE TrialFilippo Ottani, Roberto Latini, Lidia Staszewsky, et al.
Giornale Italiano Di Cardiologia (2006)|July 20, 2019
[ANMCO/SIC/GISE/ARCA/SIRM Consensus document: Description of coronary atherosclerosis for diagnostic, prognostic and therapeutic purposes]Giancarlo Casolo, Maurizio Giuseppe Abrignani, Antonio Francesco Amico, et al.
Pageof 17